Taiwanese medical AI startup Aesop Expertise has raised $2.9 million in a fundraising spherical led by Taiwania Capital forward of its Sequence A funding occasion. The spherical additionally drew the participation of Colopl Subsequent, 500 Startups, and BE Capital.
A spin-off from Taipei Medical College, the corporate was established within the US in 2020 and is now at present headquartered in San Francisco. It presents two AI-powered options: RxPrime, a medicine choice assist instrument, and a scientific documentation enchancment instrument for recognizing incorrect diagnoses referred to as DxPrime, which was launched in June this yr.
WHAT IT’S FOR
Aesop says it’ll use its contemporary funds to strengthen its expertise staff and additional broaden its presence within the US market.
THE LARGER TREND
The fundraiser comes after it launched each of its options on apps marketplaces Epic App Orchard and Olive Library over the previous few months.
Final yr, it printed a paper with Harvard College which demonstrated the worldwide transferability of its AI mannequin for detecting medicine errors in EHR techniques within the US.
